Increased Nuchal Translucency and Pregnancy Outcomes: A Tertiary Center Data
Open Access
- 17 March 2024
- journal article
- research article
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 26 (Early Acce) , 38-43
Abstract
Aim: This study aimed to evaluate the pregnancy outcomes of patients who applied to our clinic between the 11th and 14th weeks of pregnancy and whose nuchal translucency (NT) measurement was ≥1.5 multiples of the median (MoM). Material and Methods: The study included 85 patients whose NT measurement was determined ≥1.5 MoM and pregnancy results were available. Demographic characteristics of the patients, prenatal invasive diagnostic test results, fetal anomaly screening, fetal echocardiography (ECHO) results, and neonatal and obstetric results were evaluated. Results: Abnormal karyotype was detected in 10.6% (n=9) of the patients. Trisomy 21 was the most common chromosomal anomaly. Fetal structural anomaly was detected in 29.4% (n=25) of the patients. A structural fetal anomaly was detected in 21% (n=13) of fetuses with normal karyotypes and 66.7% (n=6) of fetuses with abnormal karyotypes. Cardiac anomalies were found to be the most common anomalies with 9.7% (n=6) in patients with normal karyotype. NT and NT MoM values in patients with fetal structural (both p=0.001) or chromosomal anomalies (p=0.011, and p=0.019, respectively) were found significantly higher than those without. NT and NT MoM values in patients whose pregnancies resulted in fetal loss were found significantly higher than in patients who had a live birth (both p=0.001). Conclusion: Increasing NT or NT MoM values indicate an increase in the risk of chromosomal anomalies, structural anomalies, and poor pregnancy outcomes in the fetus. Fetal anomaly screening and fetal ECHO should be recommended in patients with increased NT, even if a normal karyotype is detected.Keywords
This publication has 21 references indexed in Scilit:
- Follow-up of increased nuchal translucency: Results of a study of 398 casesJournal of Gynecology Obstetrics and Human Reproduction, 2022
- Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2015
- Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institutionPrenatal Diagnosis, 2013
- Increased nuchal translucency thickness and normal karyotype: time for parental reassuranceUltrasound in Obstetrics & Gynecology, 2007
- Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: A prospective studyAmerican Journal of Obstetrics and Gynecology, 2007
- Increased nuchal translucency with normal karyotypeAmerican Journal of Obstetrics and Gynecology, 2005
- Increased fetal nuchal translucency at 11–14 weeksPrenatal Diagnosis, 2002
- Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotypePrenatal Diagnosis, 2002
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 1995